Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform
Milan-based NanoPhoria raised €3.5 million in seed financing to advance its pre-clinical stage treatment for heart failureMILAN, ITALY / ACCESSWIRE / May 12, 2022 / Sofinnova Partners, a leading European
Source: finanznachrichten.de